Op-Eds

How to fix our medical supply chain problems

By
Published May 13, 2022 5:00am ET
Add Washington Examiner on Google
How to fix our medical supply chain problems
President Trump signed into law the FDA Reauthorization Act of 2017 on Friday. It reauthorizes a program in which drug and device makers pay the FDA a fee for every new product application, and the agency uses that money to hire more people and speed up approvals. (AP Photo/Andrew Harnik, File) | Andrew Harnik

Here we go again. Coronavirus subvariants are swirling, setting off fresh waves of infection around the nation, and indeed around the world. We need to get serious that we’re still in a public health crisis affecting the country and undermining our medical supply chain.

Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.

Tag:

COVID-19 FDA Supply chain Washington D.C.